cogentix-clinical-dataClinical Trial and Research Data

Cogentix Medical’s commitment to provide customers with safe and effective products is backed by extensive clinical data. 

Urgent® PC Neuromodulation System for overactive bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence

Office-based neuromodulation, delivered through Percutaneous Tibial Nerve Stimulation (PTNS), has been the subject of 50+ clinical publications. Up to 80% of patients respond to PTNS treatment and see significant improvements in their symptoms. 

See Urgent PC Clinical Data

EndoSheath® Protective Barrier for safe, efficient high performance endoscopy

EndoSheath Products have been used in multiple endoscopy specialties over the past twenty years. Over thirty peer-reviewed research studies have been conducted and published on the clinical implementation, endoscopic quality, and efficacy of the technology.

See EndoSheath Clinical Data

Macroplastique® Injectable Bulking Agent for adult female stress urinary incontinence

Macroplastique has been used in Europe since 1991 with excellent clinical results.  The FDA premarket approval study reinforced exceptional performance of Macroplastique as compared to the control, a currently marketed absorbable bulking agent.  There were no serious treatment-related adverse events noted in the Macroplastique group; rate and type of adverse events was similar to the Control group.

See Macroplastique Clinical Data